Thanks to the support of our generous funding partners, collaborators, and most importantly, the patients and families participating in our research studies, the Centre for Applied Neurogenetics (CAN) is able to accelerate its progressive research program with the aim of developing effective therapeutics for patients with neurological disease.
To learn more about how you can help:
CAN is developing model systems and novel therapeutics that exploit fundamental neurogenetic insights by building upon existing and establishing new national and international networks.Together, we perform cross-theme, multidisciplinary research, to end the suffering inflicted by neurologic and neurodegenerative disease. CAN’s research program builds upon and complements existing research at UBC. CAN links clinical, basic, and biotech/pharma research, integrating activities between CFRI, BRC, CDRD, PPRC, Vancouver Coastal Health Research Institute and Genome BC, with external academic and industrial partnerships. Dr. Farrer’s CERC chair is critical to UBC’s mission to expand Provincial, National and International genetic and neuroscience research efforts.
